Abstract
Serum N-terminal procollagen type III peptide (sPIIIP) levels were evaluated in 58 patients affected by chronic liver disease, in order to assess the usefulness of sPIIIP as a marker of hepatic fibrosis. In 45 patients sPIIIP was also correlated to liver histology; biopsies were scored by two of the authors, without knowledge of diagnosis. Compared to normal controls, sPIIIP concentration was found to be significantly elevated in chronic active hepatitis (CAH) and in cirrhosis, but not in fatty liver. Patients affected by chronic persistent hepatitis (CPH) had values of sPIIIP higher than normal in four of 11 cases considered. A close correlation was found between sPIIIP values and histological parameters of inflammation, necrosis, and degeneration, while the relationship between sPIIIP levels and fibrosis was weaker. These data suggest that sPIIIP determination may reflect the extent of inflammatory changes in the liver; but it cannot be considered a reliable index of hepatic fibrosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Popper H, Udenfriend S: Hepatic fibrosis. Correlation of biochemical and morphologic investigations. Am J Med 49:707–721, 1970
Rojkind M, Kershenobich K: Diagnostic procedures for liver fibrosis.In Diagnostic Procedures in the Evaluation of Hepatic Disease. G Beker (ed). New York, Alan R. Liss, 1983, pp 73–87
Bianchi L, De Groote J, Desmet VJ, Gedick P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler M, Wepler W: Acute and chronic hepatitis revisited. Lancet 2:914–918, 1977
Siegel RC, chen KH, Greenspan JS, Aguiar JM: Biochemical and immunochemical study of lysil-oxidase in experimental fibrosis in the rat. Proc Natl Acad Sci USA 75:2945–2949, 1978
Kuutti-Savolainen ER, Risteli J, Miettinen TA, Kivirikko KI: Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl-hydroxylase. Eur J Clin Invest 9:89–95, 1979
Kuutti-Savolainen ER, Anttinen H, Miettinen TA, Kivirikko KI: Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. II. Galactosyl-hydroxylysyl-glucosyl-transferase. Eur J Clin Invest 9:97–101, 1979
Foellmer HG, Kawahara K, Madri JA, Furthmayr H, Timpl R, Tuderman L: A monoclonal antibody specific for the amino terminal cleavage site of procollagen type I. Eur J Biochem 134:183–189, 1983
Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R: Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 9:451–459, 1979
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435, 1981
Niemelä O, Risteli L, Sotaniemi EA, Risteli J: Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Gastroenterology 85:254–259, 1983
Frei A, Zimmerman A, Weigand K: The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 4:830–834, 1984
Savolainen ER, Goldberg B, Leo MA, Velez M, Lieber CS: Clinical value of serum procollagen peptide radioimmunoassay in alcoholic liver disease. Hepatology 2:682, 1982 (abstract)
Volmer J, Lüders CJ: Morphometric investigation on the portal tracts of the liver, the differentiation of variable progression in chronic persistent hepatitis. Virchows Arch (Pathol Anat) 392:321–337, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Surrenti, C., Casini, A., Milani, S. et al. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?. Digest Dis Sci 32, 705–709 (1987). https://doi.org/10.1007/BF01296135
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296135